Navigation Links
'Proud Hands' Book Released to Benefit the American Parkinson Disease Association
Date:4/21/2008

olly Robinson Peete. "The 'Proud Hands' book is a great way to create awareness about a disease that affects the lives of so many people and, at the same time, give hope to those who have the disease."

"Proud Hands" is sponsored by Teva Neuroscience, marketer of the Parkinson's drug AZILECT(R) (rasagiline tablets). The book will be available through the APDA for a $15 donation, which will go to assist the organization in its research, support, and education initiatives. More information on the book is available online at http://www.proudhandsbook.com.

"It is important to let the community know that Parkinson's disease does not have to be the entire story of a person's life. The 'Proud Hands' book is a way for those affected by the disease to share this message with the world. We're honored that these courageous and inspirational people have allowed us to help spread their story that they might serve as an example to others," said Mike Sheehy, product manager for Teva Neuroscience.

The photos and stories in "Proud Hands" range both in style and content, demonstrating the full lives that people with PD can lead. Participants also vary in age and background, including those who have young-onset PD. Some examples are:

-- Yoga instructor Paul Zeiger, who has created a special yoga program for

people with PD to improve flexibility, strength and balance.

-- Elena Tuero, a mother of three, who began her career as an artist 17

years after her diagnosis at age 27, and donates many of her paintings

to help raise funds for Parkinson's research.

-- Bill Hillman, a retired coach who created and launched exercise videos

to help alleviate the symptoms of PD on You Tube

(http://www.youtube.com/watch?v=FW5fNun0mUc)

For more information visit

SOURCE Teva Neuroscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
2. @ease Spa is Proud to Participate in Spa Week
3. When Should Children Wash Their Hands?
4. Clean Hands are Key to Fighting Cold, Flu Germs
5. Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work
6. SafeHands School Program to Help Fight Spread of MRSA Staph Virus
7. Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped
8. Gynecologists Get First Hands-On Experience With Simbionix LAP Mentor(TM)
9. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
10. Two Little Hands Productions, Creators of Popular Childrens TV Series Signing Time, Debuts Second Season at This Years Toy Fair 2008
11. Qiao Xing Mobiles CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0 LCD Screen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...be held on January 8, 2009 , , TORONTO, Nov...nal Inc. ("MedEmerg") (OTCBB: MDER), one of Canada... today that it has obtained an interim order from ...ts previously announced plan of arrangement (the "...nc. ("AIM") will acquire all of MedEmerg,s outstan...
(Date:11/21/2008)...ty of Texas Health Science Center at Houston will ... Studies (TEXAS), to promote geriatrics training f...rd from the Donald W. Reynolds Foundation and $1.2... to teach geriatric medicine principles to everyon...ng physicians. With the reach of Lyndon B. Johnson...
(Date:11/21/2008)...e-FirstCall/ -- Heska Corporation,(Nasdaq: HSKA... Society of,Security Analysts, 12th Annual Biotec...2008 at 1177 Avenue of the Americas, 2nd Floor in ...gin at 9:35 a.m. Eastern Time (7:35 a.m.,Mountain...for two weeks,following the presentation through ...
(Date:11/21/2008)...-USNewswire/ -- The Generic,Pharmaceutical Associ...y from,GPhA President and CEO Kathleen Jaeger reg...ble on "Emerging Health Care Competition and Consu...is conducting this roundtable demonstrates the,gr... access to safe and,affordable biogenerics sooner...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...done in Greece to show the relationship of the pla...some interesting results.// The study took into co...plains and those living in the hills, data taken i... years, especially concerned with coronary disease...
...nity may lead you to blindness. According to a new...//scientists had been able to find out a genetic c...h of what is commonly known as blindness due to ag... that may cause macular degeneration in elderly pe...
...been successful in developing a computer aided ale...is in patients. //There had not been much attempts...t innovation is one of the first of its kind. The ...tion may be able to reduce the frequency of the co...
... that the drug Rimonabant (Acomplia) a selective ... patients keep weight off // . Supplementation wit...significant decrease in body weight and waist circ...us visceral fat. It also improved HDL (good) chole...
Other Medicine News:
(Date:11/21/2008)... THOUSAND OAKS, Calif., Nov. 21 /PRNewswire-First...that the European Committee for Medicinal,Product...on recommending,marketing authorisation for Nplat...The CHMP recommends Nplate for adult chronic immun...enectomised patients who are refractory to,other ...
(Date:11/20/2008)... SAN MARINO, Calif., Nov. 20 Epei... Phase I/II and II studies of Rexin-G in,chemothe...osteosarcoma, as,presented by Dr. Sant P. Chawla,...meetings held in London UK on November 13-15, 2008... i.v. over a period up to 9 months. Analysis of,s...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /P...K ) today announced that the United States Food an...proval for PROMACTA(R) (eltrombopag) for the treat...immune (idiopathic) thrombocytopenic purpura (ITP)...teroids, immunoglobulins or splenectomy. The appro...
(Date:11/20/2008)... RIVERSIDE, Calif., Nov. 20 Milk....better than originally thought. After years of,re...vered peptides found in,cow,s milk that stimulate..., To view the Multimedia News Release, go to:... , , While developing new cancer therapi...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2NYU American Museum of Natural History receive 241 6 million NSF grant 4686 1NYU American Museum of Natural History receive 241 6 million NSF grant 4686 2Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 1Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN 28R 29 7451 2Unexplored Arctic region to be mapped 4685 1GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 1GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 2GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 3GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza 28R 29 7448 4
...MINNEAPOLIS--(BUSINESS WIRE)--Apr 26, 2007 - A new...al of Child Neurology indicates,that a treatment f...children with cerebral palsy improves their qualit...established cost-effective,treatments. The finding...access to the treatment, known as Medtronic ITB Th...
...Two anti-aging preventative medicine doctors say t...their advocacy of prescribing,human growth hormone...th aging., DAYTONA BEACH, Fla., April 27, 2007 /PR... (HGH) was at the center of a recent New,York Time...my of,Anti-Aging Medicine (<a target="_blank" href...
Other Medicine Technology:Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4Doctors Outraged Over Growth Hormone Controversy 2
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established.,NOTE: Use of a heavy-duty wire guide is recommended.
Sheath Introducers with guidewires.
The Driver Stent design, utilizing an advanced cobalt-based alloy, surpasses the limitations of stainless steel stents. This stronger alloy makes possible thinner struts, for unparalleled flexibility
The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner.
Medicine Products: